Flow Cytometry Market Research Report Information Forecast to 2032
상품코드:1452459
리서치사:Market Research Future
발행일:2024년 03월
페이지 정보:영문 199 Pages
라이선스 & 가격 (부가세 별도)
한글목차
유세포 분석 시장 규모는 예측 기간 동안 7.47%의 연평균 복합 성장률(CAGR)로 견조한 성장을 보일 것으로 예측됩니다.
악성종양, 심혈관 질환, 면역감염증 등이 현저하게 확대되고 있으며, 유세포 분석 등 최첨단의 대증요법이나 연구기기에 대한 관심이 높아지고 있습니다. 또한 POCT에 대한 관심 증가는 유세포 분석 시장의 중요한 촉진요인이 되었습니다.
지역별로는 유세포 분석의 진보, 대규모 의료비, 깊게 뿌리를 둔 의료 서비스 기반으로 북미가 시장을 선도할 가능성이 높습니다. 또한 유럽은 2022년부터 2023년까지 중요한 시장 성장을 보였습니다. 이것은 질병 이환 증가, 유세포 분석 산업의 새로운 진보에 대한 요구의 확대, R&D에 대한 관심 증가로 인한 것입니다. 아시아태평양 시장은 중국 및 인도와 같은 신흥 경제 국가에서 의약품 및 생명 공학 회사의 확대로 가장 급속하게 발전하고 있는 지역입니다.
이 보고서는 세계의 유세포 분석 시장을 조사했으며, 시장 정의 및 개요, 시장 성장에 미치는 영향요인 및 시장 기회 분석, 시장 규모 추이 및 예측, 다양한 분류 및 지역별 분석, 경쟁 환경, 주요 기업 프로파일 등을 정리했습니다.
목차
제1장 주요 요약
제2장 시장 개요
제3장 조사 방법
제4장 시장 역학
개요
성장 촉진요인
만성질환의 이환율 증가
POC 검사 수요 증가
R&D에 대한 투자 증가
억제요인
유세포 분석 기기 및 시약의 고비용성
숙련된 경험이 풍부한 전문가의 부족
기회
다양한 분야에서의 유세포 분석의 응용 및 도입 확대
제5장 시장 요인 분석
공급망 분석
Porter's Five Forces 모델
COVID-19가 세계의 유세포 분석 시장에 미치는 영향
제6장 세계의 유세포 분석 시장 : 컴포넌트별
개요
사이토메트리 플랫폼
셀 분류기
셀 분석기
부속품
필터
레이저
검출기
기타
시약 및 소모품
항체
염료
비즈
용제
버퍼
기타
소프트웨어
서비스
제7장 세계의 유세포 분석 시장 : 기술별
개요
비드베이스
세포 기반
제8장 세계의 유세포 분석 시장 : 용도별
개요
학술 및 임상 연구
세포주기 분석 및 세포 증식
아폽토시스
선별
트랜스펙션 및 세포 생존율
기타
진단
암
면역 결핍 질환
장기 이식
기타
제9장 세계 유세포 분석 시장 : 최종 사용자별
개요
병원 및 진료소
상업 단체
의학부 및 임상 실험실
연구기관
기타
제10장 세계의 유세포 분석 시장 : 지역별
세계
북미
유럽
아시아태평양
기타 지역
제11장 경쟁 구도
개요
경쟁 벤치마킹
주요 성장 전략
개발수로의 리더기업
주요 개발 분석
주요 발전 및 성장 전략
재무 매트릭스
제12장 기업 프로파일
THERMO FISHER SCIENTIFIC, INC.
SYSMEX CORPORATION
BECKMAN COULTER, INC.
BECTON, DICKINSON AND COMPANY
MILTENYI BIOTEC
AGILENT TECHNOLOGIES, INC
CYTEK BIOSCIENCES
BIO-RAD LABORATORIES, INC.
LUMINEX CORPORATION
SARTORIUS AG
제13장 부록
AJY
영문 목차
영문목차
Market Overview
The Flow Cytometry Market is expected to register a healthy CAGR of 7.47% during the forecast period.
The elements that are driving the development of the worldwide market are the rising pervasiveness of ongoing infections and developing interest for purpose in care testing.
There has been a critical expansion in the pervasiveness of ongoing sicknesses like malignant growth, cardiovascular illnesses, immune system infections, irresistible sicknesses, and others which has prompted an expanded interest for cutting edge symptomatic and research devices, for example, flow cytometry. For example, as per World Wellbeing Association (WHO) figures, malignant growth is the essential or second driving reason for death in 112 of 183 countries before the age of 70. Likewise, GLOBOCAN 2020 assessments of disease frequency delivered by the Global Organization for Research on Malignant growth state around the world, an expected 19.3 million new disease cases in 2020.
Besides, the rising interest for purpose in care testing (POCT) has been a significant driver of the flow cytometry market. POCT alludes to indicative testing performed at or close to the patient's area, giving quick and prompt outcomes. In this specific circumstance, flow cytometry has acquired conspicuousness because of its capacity to convey continuous, high-throughput examination of individual cells, making it a significant device for decentralized demonstrative settings.
Market Segmentation
The Flow Cytometry Market is divided into five segments based on components: software, services, reagents and consumables, accessories, cytometry platforms, and others. Additionally, the cytometry platform has been divided into two sections: cell sorters and cell analyzers; accessories, further divided into filter, laser, detectors, and other categories; and reagents and consumables, further divided into categories such as antibodies, dyes, beads, solution, buffer, and other categories. Based on technology the market is divided into bead-based flow cytometry and cell-based flow cytometry. The flow cytometry market is divided into two segments based on application: diagnosis applications and applications for academic and clinical research. Based on the end user, the market is divided into hospitals and clinics, businesses, clinical labs and medical schools, research institutes, and others.
Regional Insights
North America is likely to lead the market with high sending of logically progressed flow cytometry advancements, huge medical care spending, and deeply grounded medical services foundation in the region.
Europe flow cytometry market shows critical development during the figure year, i.e., 2022-2023, attributable to the rising ongoing sickness commonness, expanding need for new advances in the flow cytometry industry, which builds request, and rising interest in research and improvement, which prompts market extension.
The Asia-Pacific flow cytometry market is the fastest developing region because of the extending drug and biotechnology enterprises in rising economies like China and India. China's rising research commitments are because of the pattern of cytometry science and innovation being an outskirts multidisciplinary research subject, drawing in a great deal of research consideration from both scholarly world and industry. Also, in Australia, research and improvement drives keep on developing.
Major Players
Major Players in the Flow Cytometry Market are Cytek Biosciences, Inc. (US), Agilent Technologies, Inc. (US), Thermo Fisher Scientific, Inc. (US), Beckman Coulter, Inc. (US), Sartorius AG (Germany), Bio-Rad Laboratories, Inc. (US), Becton, Miltenyi Biotec (Germany), Sysmex Corporation (Japan), Dickinson, and Company (US), and Luminex Corporation (US).
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
1.1 OVERVIEW
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 INCREASING PREVALENCE OF CHRONIC DISEASES
4.2.2 GROWING DEMAND FOR POINT-OF-CARE TESTING
4.2.3 INCREASING INVESTMENT IN RESEARCH AND DEVELOPMENT
4.3 RESTRAINTS
4.3.1 HIGH COST ASSOCIATED WITH FLOW CYTOMETRY INSTRUMENTS AND REAGENTS
4.3.2 SHORTAGE OF SKILLED AND EXPERIENCED PROFESSIONALS
4.4 OPPORTUNITY
4.4.1 EXPANDING APPLICATIONS AND ADOPTION OF FLOW CYTOMETRY IN DIVERSE FIELDS
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 R&D & DESIGNING
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION & SALES
5.1.4 POST-SALES MONITORING
5.2 PORTER'S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT OF SUBSTITUTES
5.2.4 BARGAINING POWER OF BUYERS
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE GLOBAL FLOW CYTOMETRY MARKET
5.3.1 IMPACT ON THE GROWTH OF THE MARKET
5.3.2 IMPACT ON TRADE OF MAJOR MANUFACTURES
5.3.3 IMPACT IN MAJOR REGIONS
5.3.4 IMPACT IN IMPACT ON THE MANUFACTURING PROCESS
6 GLOBAL FLOW CYTOMETRY MARKET, BY COMPONENT
6.1 OVERVIEW
6.2 CYTOMETRY PLATFORM
6.2.1 CELL SORTERS
6.2.2 CELL ANALYSERS
6.3 ACCESSORIES
6.3.1 FILTER
6.3.2 LASER
6.3.3 DETECTORS
6.3.4 OTHERS
6.4 REAGENTS AND CONSUMABLES
6.4.1 ANTIBODIES
6.4.2 DYES
6.4.3 BEADS
6.4.4 SOLUTION
6.4.5 BUFFER
6.4.6 OTHERS
6.5 SOFTWARE
6.6 SERVICES
7 GLOBAL FLOW CYTOMETRY MARKET, BY TECHNOLOGY
7.1 OVERVIEW
7.2 BEAD BASED FLOW CYTOMETRY
7.3 CELL BASED FLOW CYTOMETRY
8 GLOBAL FLOW CYTOMETRY MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 ACADEMIC AND CLINICAL RESEARCH APPLICATIONS
8.2.1 CELL CYCLE ANALYSIS AND CELL PROLIFERATION
8.2.2 APOPTOSIS
8.2.3 SORTING AND SCREENING
8.2.4 TRANSFECTION AND CELL VIABILITY
8.2.5 OTHERS
8.3 DIAGNOSIS APPLICATIONS
8.3.1 CANCER
8.3.1.1 LEUKEMIA
8.3.1.2 LYMPHOMA
8.3.1.3 OTHERS
8.3.2 IMMUNODEFICIENCY DISEASES
8.3.3 ORGAN TRANSPLATION
8.3.4 OTHERS
9 GLOBAL FLOW CYTOMETRY MARKET, BY END USER
9.1 OVERVIEW
9.2 HOSPITALS & CLINICS
9.3 COMMERCIAL ORGANIZATIONS
9.4 MEDICAL SCHOOLS AND CLINICAL LABS
9.5 RESEARCH INSTITUTES
9.6 OTHERS
10 GLOBAL FLOW CYTOMETRY MARKET, BY REGION
10.1 GLOBAL
10.2 NORTH AMERICA
10.2.1 US
10.2.2 CANADA
10.3 EUROPE
10.3.1 GERMANY
10.3.2 FRANCE
10.3.3 UK
10.3.4 SPAIN
10.3.5 ITALY
10.3.6 NETHERLANDS
10.3.7 REST OF EUROPE
10.4 ASIA-PACIFIC
10.4.1 CHINA
10.4.2 JAPAN
10.4.3 INDIA
10.4.4 AUSTRALIA
10.4.5 SOUTH KOREA
10.4.6 REST OF ASIA-PACIFIC
10.5 REST OF THE WORLD
10.5.1 MIDDLE EAST
10.5.2 AFRICA
10.5.3 LATIN AMERICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 COMPETITIVE BENCHMARKING
11.3 MAJOR GROWTH STRATEGY IN THE GLOBAL FLOW CYTOMETRY MARKET
11.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL FLOW CYTOMETRY MARKET
